Effects of 3-month nifedipine treatment on endocrine-metabolic parameters in patients with abdominal obesity and mild hypertension (Q38336365)

2 September 2017

title

Effects of 3-month nifedipine treatment on endocrine-metabolic parameters in patients with abdominal obesity and mild hypertension (English)

1 reference

2 September 2017

1 reference

Maccario M

1

1 reference

2 September 2017

Oleandri SE

2

1 reference

2 September 2017

Avogadri E

3

1 reference

2 September 2017

Rossetto R

4

1 reference

2 September 2017

Grottoli S

5

1 reference

2 September 2017

Procopio M

6

1 reference

2 September 2017

Camanni F

7

1 reference

2 September 2017

Ghigo E

8

1 reference

2 September 2017

publication date

1 January 1998

1 reference

Journal of Endocrinological Investigation

2 September 2017

published in

1 reference

2 September 2017

volume

21

1 reference

2 September 2017

issue

1

1 reference

2 September 2017

page(s)

56-63

1 reference

Twenty-four-hour profiles and pulsatile patterns of insulin secretion in normal and obese subjects

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF03347287

Banting lecture 1988. Role of insulin resistance in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347287

Weight and blood pressure. Findings in hypertension screening of 1 million Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347287

Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347287

Insulin and blood pressure: possible role of hemodynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347287

Insulin resistance syndrome: possible key role of blood flow in resting muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347287

Drug Treatment of Hypertension in Patients With Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347287

The effects of hyperinsulinemia on serum testosterone, progesterone, dehydroepiandrosterone sulfate, and cortisol levels in normal women and in a woman with hyperandrogenism, insulin resistance, and acanthosis nigricans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347287

Insulin and growth hormone act synergistically to stimulate insulin-like growth factor-I production by cultured chicken hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347287

Clinical review 26: Insulin resistance in obese and nonobese man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347287

Nitrendipine improves glucose tolerance and deoxyglucose uptake in hypertensive rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347287

Comparison of the effects of atenolol and nifedipine on glucose, insulin, and lipid metabolism in patients with hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347287

Possible role of cytosolic free calcium concentrations in mediating insulin resistance of obesity and hyperinsulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347287

Divergent correlations of circulating dehydroepiandrosterone sulfate and testosterone with insulin levels and insulin receptor binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347287

Decreased testosterone and dehydroepiandrosterone sulfate concentrations are associated with increased insulin and glucose concentrations in nondiabetic men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347287

6 Factors controlling blood concentration of somatomedin C

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347287

Dual defects in pulsatile growth hormone secretion and clearance subserve the hyposomatotropism of obesity in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347287

Impaired growth hormone responses to growth hormone-releasing factor in obesity. A pituitary defect reversed with weight reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347287

Circulating insulin-like growth factor I concentrations in clinically severe obese patients with and without NIDDM in response to weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347287

Nicardipine does not cause deterioration of glucose homoeostasis in man: A placebo controlled study in elderly hypertensives with and without diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347287

Disparate effects of weight reduction by diet on serum dehydroepiandrosterone-sulfate levels in obese men and women

21 January 2018

1 reference

12 December 2020

Impairment of insulin secretion in man by nifedipine

1 reference

12 December 2020

Metabolic effects of lacidipine: a placebo-controlled study using the euglycaemic hyperinsulinaemic clamp.

1 reference

12 December 2020

Hyperglycaemic effect of nifedipine

1 reference

12 December 2020

Nutritional regulation of the insulin-like growth factors

1 reference

12 December 2020

Nitrendipine treatment in women with polycystic ovarian syndrome: evidence for a lack of effects of calcium channel blockers on insulin, androgens, and sex hormone-binding globulin

1 reference

12 December 2020

Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group

1 reference

12 December 2020

Effects of nitrendipine on glucose tolerance and serum insulin and dehydroepiandrosterone sulfate levels in insulin-resistant obese and hypertensive men.

1 reference

12 December 2020

Nifedipine vs. enalapril in treatment of hypertensive patients with glucose intolerance

1 reference

12 December 2020

Massive weight loss restores 24-hour growth hormone release profiles and serum insulin-like growth factor-I levels in obese subjects

1 reference

12 December 2020

Obesity, metabolism, and the sympathetic nervous system

1 reference

12 December 2020

Endocrine and renal effects of nifedipine gastrointestinal therapeutic system in patients with essential hypertension. Results of a multicenter trial. The Modern Approach to the Treatment of Hypertension Study Group.

1 reference

12 December 2020

Blood pressure control during weight reduction in obese hypertensive men: separate effects of sodium and energy restriction.

1 reference

12 December 2020

Mechanisms of insulin resistance in human obesity: evidence for receptor and postreceptor defects

1 reference

12 December 2020

Low concentrations of insulin-like growth factor-I in abdominal obesity

1 reference

12 December 2020

Effects of nifedipine and nitrendipine on insulin secretion in obese patients

1 reference

12 December 2020

Insulin-like growth factors and their binding proteins: biological actions

1 reference

12 December 2020

Hyperinsulinemia: possible role in obesity-induced hypertension

1 reference

12 December 2020

Effect of diltiazem on skeletal muscle 3-O-methylglucose transport in bacteremic rats.

1 reference

12 December 2020

The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V)

1 reference

12 December 2020

Calcium antagonists and islet function. I. Inhibition of insulin release by verapamil

1 reference

12 December 2020

Cytosolic Calcium and Insulin Resistance in Elderly Patients With Essential Hypertension

1 reference

12 December 2020

Pharmacology of verapamil. II. Impairment of glucose tolerance by verapamil in the conscious dog

1 reference

12 December 2020

Glucocorticoid regulation of insulin-like growth factor-binding protein-3

1 reference

12 December 2020

Excessive Insulin Response to Glucose in Obese Subjects as Measured by Immunochemical Assay

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03347287

1 reference

2 September 2017

1 reference